Met Life Investment Management, LLC Atri Cure, Inc. Transaction History

Met Life Investment Management, LLC

  • $17.1 Billion
  • Q3 2024

A detailed history of Met Life Investment Management, LLC transactions in Atri Cure, Inc. stock. As of the latest transaction made, Met Life Investment Management, LLC holds 27,413 shares of ATRC stock, worth $960,277. This represents 0.0% of its overall portfolio holdings.

Number of Shares
27,413
Previous 28,322 3.21%
Holding current value
$960,277
Previous $644,000 19.25%
% of portfolio
0.0%
Previous 0.0%

Shares

41 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
SELL
$20.34 - $29.5 $18,489 - $26,815
-909 Reduced 3.21%
27,413 $768,000
Q2 2024

Aug 13, 2024
BUY
$19.86 - $29.09 $75,289 - $110,280
3,791 Added 15.45%
28,322 $644,000
Q1 2024

May 14, 2024
BUY
$28.21 - $37.78 $692,019 - $926,781
24,531 New
24,531 $746,000
Q3 2023

May 09, 2024
BUY
$41.12 - $57.73 $16,036 - $22,514
390 Added 1.62%
24,531 $1.07 Million
Q2 2023

Apr 29, 2024
BUY
$40.44 - $49.6 $992,033 - $1.22 Million
24,531 New
24,531 $1.21 Million
Q2 2023

Aug 10, 2023
BUY
$40.44 - $49.6 $15,771 - $19,344
390 Added 1.62%
24,531 $1.21 Million
Q1 2023

May 09, 2024
BUY
$35.87 - $47.22 $865,937 - $1.14 Million
24,141 New
24,141 $1 Billion
Q1 2022

May 10, 2024
BUY
$57.43 - $71.39 $1.39 Million - $1.72 Million
24,141 New
24,141 $1.59 Million
Q1 2022

Mar 22, 2023
BUY
$57.43 - $71.39 $490,969 - $610,313
8,549 Added 54.83%
24,141 $1.59 Million
Q1 2022

May 12, 2022
BUY
$57.43 - $71.39 $490,969 - $610,313
8,549 Added 54.83%
24,141 $1.59 Million
Q4 2021

Jun 21, 2023
SELL
$63.4 - $87.14 $542,006 - $744,959
-8,549 Reduced 35.41%
15,592 $1.08 Million
Q3 2021

May 17, 2024
SELL
$69.28 - $84.46 $77,524 - $94,510
-1,119 Reduced 6.7%
15,592 $1.08 Million
Q3 2021

Jun 21, 2023
SELL
$69.28 - $84.46 $592,274 - $722,048
-8,549 Reduced 35.41%
15,592 $1.08 Million
Q3 2021

Mar 22, 2023
SELL
$69.28 - $84.46 $77,524 - $94,510
-1,119 Reduced 6.7%
15,592 $1.08 Million
Q3 2021

Nov 15, 2021
SELL
$69.28 - $84.46 $77,524 - $94,510
-1,119 Reduced 6.7%
15,592 $1.08 Million
Q2 2021

Jun 21, 2023
SELL
$64.13 - $80.18 $476,485 - $595,737
-7,430 Reduced 30.78%
16,711 $1.33 Million
Q1 2021

May 17, 2024
SELL
$53.79 - $66.98 $420,637 - $523,783
-7,820 Reduced 31.88%
16,711 $1.09 Million
Q1 2021

Jun 26, 2023
SELL
$53.79 - $66.98 $399,659 - $497,661
-7,430 Reduced 30.78%
16,711 $1.09 Billion
Q1 2021

Mar 22, 2023
SELL
$53.79 - $66.98 $103,976 - $129,472
-1,933 Reduced 10.37%
16,711 $1.09 Million
Q1 2021

May 14, 2021
SELL
$53.79 - $66.98 $103,976 - $129,472
-1,933 Reduced 10.37%
16,711 $1.1 Million
Q4 2020

Jun 22, 2023
SELL
$34.56 - $57.55 $189,976 - $316,352
-5,497 Reduced 22.77%
18,644 $1.04 Million
Q3 2020

May 24, 2024
BUY
$38.36 - $46.91 $47,950 - $58,637
1,250 Added 7.19%
18,644 $744 Million
Q3 2020

Jun 26, 2023
SELL
$38.36 - $46.91 $210,864 - $257,864
-5,497 Reduced 22.77%
18,644 $743,000
Q3 2020

Mar 22, 2023
BUY
$38.36 - $46.91 $47,950 - $58,637
1,250 Added 7.19%
18,644 $743,000
Q3 2020

Nov 13, 2020
BUY
$38.36 - $46.91 $47,950 - $58,637
1,250 Added 7.19%
18,644 $744,000
Q2 2020

May 24, 2024
SELL
$31.78 - $51.19 $226,813 - $365,343
-7,137 Reduced 29.09%
17,394 $782 Million
Q2 2020

Jun 26, 2023
SELL
$31.78 - $51.19 $214,419 - $345,378
-6,747 Reduced 27.95%
17,394 $781,000
Q2 2020

Mar 22, 2023
BUY
$31.78 - $51.19 $35,720 - $57,537
1,124 Added 6.91%
17,394 $781,000
Q2 2020

Aug 14, 2020
BUY
$31.78 - $51.19 $35,720 - $57,537
1,124 Added 6.91%
17,394 $782,000
Q1 2020

Jul 12, 2023
SELL
$24.49 - $43.84 $192,760 - $345,064
-7,871 Reduced 32.6%
16,270 $546,000
Q4 2019

Jul 12, 2023
SELL
$24.06 - $32.51 $189,376 - $255,886
-7,871 Reduced 32.6%
16,270 $528,000
Q3 2019

Jul 12, 2023
SELL
$23.81 - $32.52 $187,408 - $255,964
-7,871 Reduced 32.6%
16,270 $405,000
Q2 2019

Jul 12, 2023
SELL
$26.85 - $30.74 $211,336 - $241,954
-7,871 Reduced 32.6%
16,270 $485,000
Q1 2019

Jul 13, 2023
SELL
$26.38 - $33.34 $207,636 - $262,419
-7,871 Reduced 32.6%
16,270 $435,000
Q4 2018

Jul 13, 2023
SELL
$26.66 - $34.85 $209,840 - $274,304
-7,871 Reduced 32.6%
16,270 $497,000
Q4 2018

Mar 22, 2023
SELL
$26.66 - $34.85 $237,593 - $310,583
-8,912 Reduced 35.39%
16,270 $497,000
Q4 2018

Feb 14, 2019
SELL
$26.66 - $34.85 $237,593 - $310,583
-8,912 Reduced 35.39%
16,270 $498,000
Q3 2018

Jul 13, 2023
SELL
$27.62 - $35.58 $217,397 - $280,050
-7,871 Reduced 32.6%
16,270 $569,000
Q3 2018

Mar 22, 2023
BUY
$27.62 - $35.58 $28,752 - $37,038
1,041 Added 4.31%
25,182 $882,000
Q3 2018

Nov 14, 2018
BUY
$27.62 - $35.58 $246,149 - $317,088
8,912 Added 54.78%
25,182 $882,000
Q4 2017

Feb 15, 2018
BUY
$17.69 - $23.44 $287,816 - $381,368
16,270
16,270 $297,000

Others Institutions Holding ATRC

# of Institutions
212
Shares Held
49.7M
Call Options Held
12K
Put Options Held
7.2K
View Full List

About AtriCure, Inc.

ATRC Quotes by TradingView
  • Ticker ATRC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 46,424,700
  • Market Cap $1.63B
  • Description
  • AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation...
More about ATRC
Track This Portfolio

Track Met Life Investment Management, LLC Portfolio

Follow Met Life Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email